Global Public Private Partnership: An Analogical Reasoning Model
This paper aims to introduce a new strategic direction for the multinational pharmaceutical companies in terms of the access to essential, life-saving medicines. The multinational pharmaceutical companies have been severely criticized by their various stakeholders because of their business models, particularly because of the stringent patent protection on the pharmaceutical products. The multinational pharmaceutical companies should find a new strategic direction to balance their R&D-intensive, expensive business with the access to essential, lifesaving medicines since favorable public relations are critical for the multinational pharmaceutical companies to maintain their profitable business. This paper adopts an Analogical Reasoning Model (ARM) to propose a new strategic direction for the multinational pharmaceutical companies in an effort to balance their expensive business with the enhanced social responsibility. In essence, the ARM helps the multinational pharmaceutical companies formulate viable strategies that can realize a win-win situation not only for their stakeholders but also for the pharmaceutical companies themselves. The ARM is constructed, analyzing the food and beverage industry as a source environment, and suggests a comprehensive, industry-wide, multi-stakeholder public-private partnership, led not by the public sector but by the multinational pharmaceutical companies.
Volume (Year): XIII (2015)
Issue (Month): 1 (May)
|Contact details of provider:|| Postal: Str. A.I. Cuza nr. 13, Craiova|
Phone: 004 0251 411317
Fax: 004 0251 411317
Web page: http://feaa.ucv.ro/
More information through EDIRC
References listed on IDEAS
Please report citation or reference errors to , or , if you are the registered author of the cited work, log in to your RePEc Author Service profile, click on "citations" and make appropriate adjustments.:
- World Bank, 2006. "Repositioning Nutrition as Central to Development : A Strategy for Large Scale Action," World Bank Publications, The World Bank, number 7409, September.
- Patricia Danzon, 1997. "Price Discrimination for Pharmaceuticals: Welfare Effects in the US and the EU," International Journal of the Economics of Business, Taylor & Francis Journals, vol. 4(3), pages 301-322.
- Farid Gasmi & Paul Noumba Um & Laura Recuero Virto, 2009.
"Political Accountability and Regulatory Performance in Infrastructure Industries: An Empirical Analysis,"
World Bank Economic Review,
World Bank Group, vol. 23(3), pages 509-531, October.
- Gasmi, Farid & Noumba Um, Paul & Virto, Laura Recuero, 2006. "Political accountability and regulatory performance in infrastructure industries : an empirical analysis," Policy Research Working Paper Series 4101, The World Bank.
When requesting a correction, please mention this item's handle: RePEc:aio:manmar:v:xiii:y:2015:i:1:p:188-204. See general information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Catalin Barbu)
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If references are entirely missing, you can add them using this form.
If the full references list an item that is present in RePEc, but the system did not link to it, you can help with this form.
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your profile, as there may be some citations waiting for confirmation.
Please note that corrections may take a couple of weeks to filter through the various RePEc services.